Cibinqo 100 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FFHS5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,737
Award facts
- Contract value 100% obligated
- $45,737.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order valued at $45,737.43 by the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of CIBINQO 100 mg tablets in quantities of 30s. The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award through open competition. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026.
The delivery order fulfills critical pharmaceutical supply needs for federal military and veteran healthcare systems. CIBINQO (baricitinib) is a Janus kinase inhibitor used in the treatment of rheumatoid arthritis and other immune-mediated conditions, representing the type of specialty medication included within AmerisourceBergen's extensive portfolio of brand-name and generic drugs supplied to the Defense Health Agency and other federal healthcare customers. As a major pharmaceutical distributor with demonstrated capability to meet federal procurement requirements, AmerisourceBergen continues to serve as a critical vendor for the DLA's medical supply chain across multiple therapeutic domains and delivery modalities.
Quick answers
Who was awarded contract SPE2DB25FFHS5?
SPE2DB25FFHS5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FFHS5 worth?
The government has obligated $45,737 on SPE2DB25FFHS5.
Is contract SPE2DB25FFHS5 an order under another contract?
Yes. SPE2DB25FFHS5 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FFHS5 competed?
The extent of competition for SPE2DB25FFHS5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award